Cognitant Group has announced that UCB will support the launch of its new interactive healthcare service, which “seeks to provide high-quality health information” to patients being prescribed a medicine to treat arthritis.
The company aims to help patients to understand all aspects of their consultation with the platform, and in turn, better self-manage their disease.
The programme is supported by an educational grant from UCB, and developed in partnership with Cambridge Arthritis Research Endeavour (CARE).
As part of the interactive service, patients will have access to an interactive explanation of the disease process, and the mode of action of the medicine used to treat it.
The system also features a 360-degree video of an injection demo, and a series of infographics and virtual objects to aid knowledge retention.
The company also revealed that the programme entails virtual consultations with a consultant rheumatologist and nurse, intended to improve compliance with medication and ensure better outcomes for the patients by prescribing interactive health information.
Under the new system, the doctor will prescribe information to patients using the healthinote app, a platform that provides immersive experiences across a range of chronic diseases, the Cognitant Group website or a printed code. The patient will then be able to access the content using a simple QR code or link.
Tim Ringrose, chief executive officer of Cognitant Group said that the company “aims to ensure that all patients have access to the most comprehensive and personalised health information.”
He continued, “By transporting people into a virtual world, complex information can be visualised and explained as clearly as possible.
“To have received backing from this leading biopharma company reflects their confidence in our proposition to empower patients to take control of their health.”
The new technology will be user tested in Addenbrooke’s Hospital in Cambridge, UK.